Next Article in Journal
Nurses’ Perceptions of Patient Fibromyalgia Illness Experiences after Performing Group-Based Problem-Solving Therapy: A Qualitative Research Study
Next Article in Special Issue
Practices and Perceptions of Community Pharmacists in the Management of Atopic Dermatitis: A Systematic Review and Thematic Synthesis
Previous Article in Journal
Relationship between Body Mass Index and Diagnosis of Overweight or Obesity in Veterans Administration Population
Previous Article in Special Issue
Patient Safety Culture in the Southern Region of Saudi Arabia: A Survey among Community Pharmacies
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Healthcare
Volume 11
Issue 11
10.3390/healthcare11111530
healthcare-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Community Pharmacists’ Experiences and Attitudes towards the Provision of Sexual and Reproductive Health Services: An International Survey

by
Javiera Navarrete
1,
Christine A. Hughes
1,*,
Nese Yuksel
1,
Theresa J. Schindel
1,
Shigeo Yamamura
2,
Tomoko Terajima
3,
Tatta Sriboonruang
4,
Chanthawat Patikorn
4 and
Puree Anantachoti
4
1
Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, AB T6G 2H1, Canada
2
Faculty of Pharmaceutical Sciences, Josai International University, Chiba 283-8555, Japan
3
Faculty of Pharmaceutical Sciences, Shonan University of Medical Sciences, Kanagawa 244-0806, Japan
4
Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand
*
Author to whom correspondence should be addressed.
Healthcare 2023, 11(11), 1530; https://doi.org/10.3390/healthcare11111530
Submission received: 24 April 2023 / Revised: 19 May 2023 / Accepted: 22 May 2023 / Published: 24 May 2023
(This article belongs to the Special Issue Pharmacy Practice and Administration 2.0)
Browse Figures
Versions Notes

Abstract

:
Access to comprehensive sexual and reproductive health (SRH) services remains a challenge worldwide. Describing community pharmacists’ SRH services in countries with different scopes of practice will aid in understanding how pharmacists view their roles and how to support them in providing needed services. A cross-sectional web-based survey was administered to pharmacists working in community pharmacies in Japan, Thailand, and Canada. The survey covered 7 SRH categories: pregnancy tests, ovulation tests, contraception, emergency contraception, sexually transmitted and blood-borne infections, maternal and perinatal health, and general sexual health. Descriptive statistics were used to analyze the data. A total of 922 eligible responses were included in the analysis (Japan = 534, Thailand = 85, and Canada = 303). Most Thai and Canadian participants reported dispensing hormonal contraceptives (Thailand = 99%, Canada = 98%) and emergency contraceptive pills (Thailand = 98%, Canada = 97%). Most Japanese participants provided patient education on barrier contraceptives for men (56%) and information on the safety of medications in pregnancy (74%) and breastfeeding (76%). The majority of participants expressed interest in additional training and expanding their roles in SRH. Sharing international experiences can guide challenges faced by the evolution of pharmacists’ practice in SRH. Providing pharmacists support could help their readiness for this role.

1. Introduction

Access to comprehensive sexual and reproductive health (SRH) services remains a challenge worldwide. According to the World Health Organization (WHO), 4.3 billion people of reproductive age worldwide will not have access to at least one SRH intervention in their lifetime [1]. More recently, the COVID-19 pandemic has significantly impacted the provision of these services [2,3,4,5,6,7,8,9]. Fear of accessing in-person care, medication shortage, suspended services and care programs have limited access to SRH services during the pandemic [2,3,8]. As the current global agenda includes ensuring accessible and high-quality SRH services for everyone [10], finding more options for access to these services is important.
The evolution of pharmacy practice is an international phenomenon. Development, adoption, and integration of new roles and responsibilities by pharmacists have been the trend over the past few decades [11,12,13]. Balancing professional, clinical and economic considerations and adopting new roles of pharmacists are challenges for the profession worldwide [14]. Evidence for the benefits of pharmacists’ involvement in the delivery of SRH services is growing. Pharmacists have been recognized as competent and trustworthy healthcare professionals expanding access to a wide range of SRH services [15,16]. A scoping review highlighted that pharmacists’ roles in SRH have evolved beyond traditional product-focused services, such as treatment of sexually transmitted and bloodborne infections (STBBI) and contraception prescribing [16]. Challenges with the provision of SRH services by pharmacists reported in studies include integration into the pharmacy daily workflow, remuneration, cost and reimbursement for patients, and policy regulations [16]. However, most literature is from the US and UK, and there is little research describing international contexts and identifying how pharmacists can serve those needing to access SRH services.
Several factors prevent the translation of contemporary patient-oriented pharmacy practice models globally [17,18]. One of these factors is the quality and availability of information about pharmacists’ current scope of practice [17,18]. Pharmacy practice has steadily advanced over the past few decades, but significant variations in the scope of practice have been described [19]. As there is a lack of universal practice standards across pharmacy settings and countries due to differences in healthcare systems, public health agenda, pharmacy curricula, professional regulations, continuing education, and pharmacists’ compensation for professional services [18], research highlighting these differences is crucial to understand the current state of SRH services and opportunities to influence and promote further expansion of pharmacist’ roles in this area [17,20].
Given the prominent role in communities as part of primary health care, describing community pharmacists’ SRH services in countries with a different scope of practice will aid in understanding how pharmacists view their roles, see themselves as SRH providers, and what support they need to provide SRH services. To our knowledge, there is limited information regarding pharmacists’ experiences as SRH providers in Canada [21,22,23,24], and no research has described SRH services in Thailand and Japan. This study aims to explore SRH services provided by pharmacists practicing in community pharmacies in Japan, Thailand, and Canada. The secondary objectives are to identify perceived factors influencing the delivery of services and training preferences to support role expansion in each country.

1.1. Study Context

Pharmacy Education and Scope of Practice

The general characteristics and differences among educational programs, pharmacy regulations, and scope of practice between Japan, Canada, and Thailand are highlighted in Table 1.
The number of years required to obtain a pharmacy degree is similar in these countries. In Japan, completing the extended Bachelor of Pharmacy (6 years) is mandatory to qualify for the national examination for entry to practice. Influenced by the US-Thai consortium, Thailand developed their first Doctor of Pharmacy (PharmD) program in 1999. Since 2014, a 6-year PharmD program has been compulsory for national licensure [25]. Pharmacy programs in Canada implemented the PharmD degree by 2020 [26].
The scope of practice differs in each country. In Canada, Alberta is the province with the broadest scope of practice and was the first to implement prescribing authority for pharmacists in 2007 [27]. Legislation in Alberta allows pharmacists to access information in patients’ electronic health records, administer drugs by injection, order laboratory tests, and prescribe medications, including independent prescribing (additional prescribing authorization or APA) [27,28]. As a result, pharmacists in Alberta can prescribe hormonal contraception and administer progestin-only injectable contraceptives, as well as vaccines.
Pharmacy practice in Japan is principally focused on dispensing medications and providing patient counselling [29]. However, authorities and professionals in Japan are exploring how pharmacists’ roles could address different health needs [29]. Sexual freedom, recognition of health risks, and access to SRH services are current public health concerns [30]. Pharmacists are ideally situated to enhance access to services. Currently, the scope of practice allows Japanese pharmacists to counsel and educate patients on SRH topics such as pregnancy and ovulation tests, contraception as well as dispense medications prescribed by a physician [30,31].
In the last decade, Thailand has expanded community pharmacists’ roles to meet the needs of the public. After more than 10 years since transitioning to a 6-year PharmD program [32], community pharmacists offer medication reviews, risk assessments, smoking cessation and some screening services [33,34]. As part of the Universal Health Coverage Scheme, the community pharmacy is a primary care unit of the system, and pharmacists are involved in addressing several public health concerns, including adolescent pregnancy and birth rates, STBBI incidence and treatment rates [35,36,37].
Table
Table 1. General characteristics, pharmacy education, and practice in Japan, Thailand, and Canada.
Table 1. General characteristics, pharmacy education, and practice in Japan, Thailand, and Canada.
JapanThailandCanada
General characteristics [38,39,40,41,42]
  Population (millions) 125.771.638.25
  Licensed pharmacists 302,50047,52548,134
  Community Pharmacies 180,41520,51611,554
Pharmacy education [26,35,43,44,45]
  No. of pharmacy educational programs741910
  Current academic credentialBPharmPharmDPharmD
  Length of current program (years)664
  Pre-pharmacy requirements (years)--2
  First year of transition from BPharm to a PharmD program (or extended BPharm)200319992007
  Completion year of transition to an all-PharmD (or extended BPharm) program200620102020
  National examination for entry to practiceYesYesYes
Community pharmacy scope of practice [27,28,29,33,45,46,47,48]
  Availability of open-shelf drugs at the pharmacyNoYesYes
  Dispensing prescription medicationsYesYesYes
  Prescribing authorizationNoNoYes
  Administration of injectionsNoNoYes
  Performing assessment based on symptomsNoYesYes
  Performing point-of-care testingNoNoYes
  Patient counselling and educationYesYesYes
BPharm, Bachelor of Science in Pharmacy; PharmD, Doctor of Pharmacy.

2. Materials and Methods

2.1. Study Design

This was a descriptive, cross-sectional international study using survey methods. Results were analyzed and reported following the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline for cross-sectional studies [49].
An anonymous, web-based survey was distributed electronically in Japan, Thailand, and Canada (Alberta) using REDCap. REDCap is an electronic data capture tool hosted by the Women & Children’s Health Research Institute at the University of Alberta [50,51]. The survey was directed to pharmacists working in a community setting. Initially, a screening question was used to capture this information and access the survey.
The survey was conducted from June 2020 to June 2021, with each country distributing the survey at different times. The period to collect responses was 1 to 6 months; in Thailand and Japan, the survey was open for 6 months due to slower response. Details about the strategies used are provided in Table 2.

2.2. Instrument

The development and content of the survey have been described previously [52,53]. The instrument was developed by the research team. A literature review informed the content, and the instrument was reviewed by experts in each country. The survey was first developed in English, then translated into Japanese and Thai, and adapted to each country’s scope of pharmacist practice. The research team members and experts from Japan and Thailand reviewed the instrument for accurate translation.
The survey covered 7 common SRH categories: pregnancy tests, ovulation tests, contraception (non-hormonal and hormonal), emergency contraception, sexually and blood-borne transmitted infections, maternal and perinatal health, and general sexual health, and included 6 sections: demographics, provision of SRH services, attitudes towards the provision of SRH services, confidence when educating patients on SRH topics, factors influencing the provision of SRH services, and additional training preferences (Supplementary File S1). The survey distributed in Alberta covered additional topics reflecting the scope of practice in the region, such as the administration of injections and prescribing. Findings related to the expanded scope of practice in Alberta [53] and attitudes and practices of Japanese pharmacists regarding reproductive health services [52] have been previously published.

2.3. Variables

A 5-point Likert-type scale was used to assess attitudes towards (strongly disagree, disagree, neutral, agree, strongly agree) and factors influencing the provision of SRH services (no impact on the services, no effect on the services, little impact on the services, neutral, somewhat impacts the services, impacts the services to a great extent). The primary outcomes were the proportion of participants providing SRH services, the proportion of participants agreeing (or disagreeing) with a series of statements regarding pharmacists as SRH providers and the influence of factors in the provision of SRH services. Secondary outcomes were the proportion of participants interested in expanding their roles in SRH and additional training preferences, including SRH knowledge and competencies.

2.4. Bias

Survey responses were anonymous. A neutral language was used when designing the survey questions to minimize response bias. Increasing the number of days the survey was open and sending invitation and reminder emails were strategies used to reduce non-response bias and improve response rates [54,55,56].

2.5. Sample Size

There was no sample size set a priori.

2.6. Data Analysis

For analysis, eligibility was defined as submitted survey responses. Partial and unsubmitted responses were not included. Descriptive statistics were used to analyze the variables. Analysis was performed using Microsoft® Excel v.16.70 (Microsoft Corporation 2018).

2.7. Ethical Approval

This study received approval from the Josai International University Research Ethics Review Committee (10M200001), the Chulalongkorn University Research Ethics Review Committee (114.1/63), and the University of Alberta Health Research Ethics Board (Pro00095881).

3. Results

3.1. Participants

A total of 1,265 pharmacists attempted the survey (Japan = 743, Thailand = 121, Canada = 401), and 922 eligible responses from community pharmacists were included in the analysis (Japan = 534, Thailand = 85, Canada = 303). Participants were primarily female and between 20 and 40 years of age (Table 3). Regarding education and experience, most participants had a Bachelor of Pharmacy degree (Japan = 94%, Thailand = 55%, Canada = 79%). In Japan and Canada, most worked in a corporate/chain pharmacy (61% and 57%, respectively), whereas 79% worked in an independent pharmacy in Thailand.

3.2. Provision of SRH Services

All categories of SRH services were, to some extent, provided in the three countries (Table 4). However, differences in involvement with the provision of these services were noted. In general, most participants from Thailand and Canada provided the services captured in the survey. Most of these participants reported dispensing combined hormonal contraceptives (Thailand = 99%, Canada = 98%) and emergency contraceptive pills (Thailand = 98%, Canada = 97%). Education on combined hormonal contraceptive methods, STBBI treatment, and maternal and perinatal health were also highly reported services (Thailand = 93–99%, Canada = 82–98%). Most Japanese participants provided patient education on barrier contraceptives for men (56%) and information on the safety of medications in pregnancy (74%) and breastfeeding (76%). A smaller number of Japanese participants provided and educated on emergency contraceptive pills (7% and 15%, respectively), educated patients on STBBI prevention (13%) and treatment (18%), and eighteen percent addressed the sexual health needs of lesbian, gay, bisexual, transgender, queer or questioning, intersex, asexual, and more (LGBTQ+) individuals.

3.3. Attitudes towards the Provision of SRH Professional Pharmacy Services

Overall, participants’ attitudes in all three countries were positive toward pharmacists’ roles in SRH (Figure 1). Most participants strongly agreed or agreed that offering advice on SRH is an essential part of community pharmacists’ roles (Japan = 80%, Thailand = 95%, Canada = 93%) and that they had an ethical responsibility as pharmacists to provide SRH services (Japan = 67%, Thailand = 97%, Canada = 89%). Japanese participants were more likely to strongly disagree or disagree with statements regarding the need for SRH services in their local area (25%) and the use of SRH services by young people (56%). Sixty-four percent of Thai participants and 68% of Canadian participants believed pharmacists are adequately trained to provide SRH services, while over half of Japanese participants disagreed with this statement.

3.4. Perceived Factors Influencing the Provision of SRH Professional Pharmacy Services

In general, most participants from the three countries responded that all factors included in the survey influenced the provision of SRH services to some extent (Figure 2). In Japan, 93% of participants indicated pharmacists’ knowledge “somewhat impacts the service” or “impacts the services to a great extent.” Similarly, most Thai and Canadian participants highlighted the influence of pharmacists’ knowledge (83% and 86% respectively). A higher percentage of all Canadian participants indicated pharmacy staffing (91%) influenced the provision of these services to a great extent, as compared to Japanese (74%) and Thai participants (80%). Compensation for the service “somewhat impact the service” or “impact the services to a great extent” for about half of participants in Japan and Thailand (56% and 46%, respectively), whereas for Canadian participants compensation had more impact on the provision of SRH services (77%).

3.5. Preferences for Additional Training on SRH

Most respondents expressed interest in additional training in SRH services (Japan = 79%, Thailand = 91%, Canada = 84%). More than half of the participants in Japan (54%) and about three-quarters of the participants in Thailand and Canada (77% and 71%, respectively) were interested in expanding their roles in SRH.
Participants’ preferences varied between countries. For Japanese participants interested in additional training, the top preferences were emergency contraception (77%) and hormonal contraceptives (63%), followed by pregnancy/postpartum/breastfeeding (59%). Additionally, the preferred areas for Thai participants were sexual dysfunction (68%), pregnancy/postpartum/breastfeeding (59%), and sexual health concerns of LGBTQ+ patients (55%). In Canada, approximately half of the participants or more preferred more training in the areas of STBBI treatment (64%), STBBI prevention (55%), and sexual health concerns of LGBTQ+ patients (50%) (Figure 3).
In terms of SRH competencies, more than 60% reported interest in additional training related to the use of appropriate and straightforward language when counselling patients (Japan = 70%, Thailand = 66%, Canada = 60%). This was the preferred choice for participants in Japan and Thailand, while for Canadian participants, their top selection was additional training on providing referrals (75%). Less than half of the participants reported interest in additional training related to confidentiality and privacy (Japan = 41%, Thailand = 31%, Canada = 29%). A higher proportion of Japanese participants considered approaching individuals nonjudgmentally a relevant topic for training (55%) (Figure 4).

4. Discussion

This multi-country study examined SRH services provided by pharmacists from regions with different regulations around pharmacy practice and perspectives regarding SRH. Results showed that pharmacists were involved in providing SRH services and had a positive attitude towards pharmacists’ roles in SRH. Participants’ perceptions of factors influencing the provision of SRH were similar in the three countries, as well as the willingness to expand roles and receive additional SRH training. The findings from this study can be used to inform education and training needs as well as potential barriers to the adoption of SRH services offered by community pharmacists.
Overall, a high percentage of Alberta pharmacists reported providing patient education across several SRH areas in addition to the provision of emergency contraception. This may be a reflection of changes in the scope of practice [57] and health policy and regulations in Alberta, Canada. In Thailand, pharmacy practice has evolved as well, and SRH services have been recognized as a pharmacy service [33]. Thai participants were highly involved with patient education in SRH, including emergency contraception and STBBI treatment and prevention. In Japan, the evolution of pharmacy practice has been more gradual compared to the other two countries [29,45]. In addition, sexual freedom, recognition of health risks, and access to SRH services are more recent public health concerns [31,58,59,60]. Overall, a lower percentage of Japanese participants provided SRH services included in this survey, including emergency contraception. Participants were more likely to report giving information related to the safety of medications in pregnancy and breastfeeding.
We found that community pharmacists from countries with different scopes of practice see themselves as SRH providers and consider offering advice on SRH topics an essential part of their roles. Still, they face similar challenges when providing SRH services. Regardless of differences in educational, economic, and healthcare system contexts, a set of competencies essential for patient care practice are similar in all regions [17,61]. Provision of SRH services, along with professional ethics and collaboration with patients and other health care providers, align with participants’ views to meet patients’ needs as SRH providers. All factors included in this survey were reported to influence the provision of SRH services to some extent. Knowledge of SRH, pharmacy staffing, and pharmacists’ compensation were some of the main influencing factors for participants. Previous studies have identified barriers to implementing pharmacy services, including pharmacists’ knowledge and the time required to provide the services [16,62].
One of the common findings was the willingness to receive more SRH training. However, the top preferences differed between countries, which can be influenced by the role participants associate with being an SRH provider. The focus of Japanese participants was emergency contraception, one of the main SRH discussion topics on the public agenda in Japan [30]. It is not surprising that Japanese pharmacists are interested in learning more about emergency contraception as their responsibilities have changed recently and will continue to change [52]. Alberta participants’ primary preference was STBBI treatment. A syphilis outbreak was declared in 2019 [63]. Incidence rates of other sexually transmitted infections (chlamydia, gonorrhea) have continued to increase [64]. At the same time, the incidence of the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) have not declined despite the availability of treatment and prevention tools [65]. In Thailand, sexual dysfunction was the most preferred topic for additional training. The high demand for medicines for sexual dysfunction [66,67], the challenges of their distribution (e.g., sildenafil is largely misused and is one of the most counterfeited drugs worldwide) [68], and the widespread use of herbal products with no scientific evidence for sexual health dysfunction may explain the preference of Thai participants.
To position pharmacists as SRH providers and increase access to SRH services, it is relevant that they see themselves as SRH providers. Recognizing that pharmacists’ process to identify as SRH providers is dynamic, complex, and influenced by many factors will help to find the best tools and strategies to support their identity formation. Sharing international experiences on the influence of the changes in the profession can help to face challenges brought by this process. Exploring what different countries do to support their pharmacy workforce to prepare them to be SRH providers can inform the development of training programs and implementation strategies customized to the practice environment. Expanding the offer of continuing education programs and creating pharmacist-specific guidelines and practice tools based on the context of each jurisdiction are some of the recommendations of this work.

Strengths and Limitations

The strengths of this study include the description of community pharmacists’ perspectives regarding the provision of SRH services in Canada, Japan, and Thailand. This study is the first to characterize perceptions of SRH practice in several topics from pharmacists in countries with different scopes of practice. Despite these strengths, several limitations need to be considered. This study may not be generalized to other regions in the selected countries and nations. Due to our study design, the results are limited due to volunteer, acquiescence, social desirability, and non-response bias. The sample size was not calculated a priori, and the number of participants varied between countries. No current detailed pharmacy workforce statistics are available to consider the representativeness of the population we aimed to survey in Japan and Thailand. However, the representativeness of this sample of the Canadian (Alberta) pharmacists’ population has been described before [53]. The survey was developed and distributed during the COVID-19 pandemic, which impacted the distribution and recruitment processes, resulting in slightly different methods and timelines used in the three countries. In addition, the global health crisis may have affected pharmacists’ workload and impacted our response rates.

5. Conclusions

Community pharmacists in countries with different scopes of practice and pharmacy regulations reported providing services in several SRH areas. While the extent to which pharmacists self-report the provision of SRH services varied in each country, pharmacists were interested in expanding SRH services and additional SRH training. Addressing factors that influence the provision of SRH services and supporting pharmacists is essential for expanding access. Sharing international experiences can guide challenges faced with the evolution of practice in SRH. Introducing support strategies based on local needs and international experiences, such as creating continuing education opportunities and practice tools, could help support pharmacists in providing care for individuals seeking SRH services.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/healthcare11111530/s1, File S1: SRH survey.

Author Contributions

Conceptualization, C.A.H., N.Y., T.J.S. and S.Y.; methodology, J.N., C.A.H., N.Y., T.J.S., S.Y., T.T., T.S., C.P. and P.A.; formal analysis, J.N. and C.A.H.; investigation, J.N.; data curation, J.N.; writing—original draft preparation, J.N. and C.A.H.; writing—review and editing, J.N., C.A.H., N.Y., T.J.S., S.Y., T.T., T.S., C.P. and P.A.; visualization, J.N. and C.A.H.; supervision, C.A.H.; project administration, C.A.H.; funding acquisition, C.A.H., N.Y., T.J.S. and S.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta (The Taiho Fund).

Institutional Review Board Statement

This study received approval from the Josai International University Research Ethics Review Committee (10M200001), the Chulalongkorn University Research Ethics Review Committee (114.1/63), and the University of Alberta Health Research Ethics Board (Pro00095881).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

The authors wish to acknowledge the support of the EPICORE Centre and the Alberta SPOR Support Unit Consultation and Research Services in the online survey development and distribution, data management, and statistical services. JN acknowledges the National Agency for Research and Development (ANID)/Scholarship program for supporting her research (Master Becas Chile/2018—73190318).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. World Health Organization. Sexual Health. Available online: https://www.who.int/topics/sexual_health/en/ (accessed on 10 April 2023).
  2. Lindberg, L.D.; VandeVusse, A.; Mueller, J.; Kirstein, M. Early Impacts of the COVID-19 Pandemic: Findings from the 2020 Guttmacher Survey of Reproductive Health Experiences; Guttmacher Institute: New York, NY, USA, 2020; Available online: https://www.guttmacher.org/sites/default/files/report_pdf/early-impacts-covid-19-pandemic-findings-2020-guttmacher-survey-reproductive-health.pdf (accessed on 20 April 2023).
  3. Dupuis, E.; Ali-Gami, J.; Wisofchi, S. The Right to Sexual and Reproductive Health—Challenges and Possibilities during COVID 19: A Canadian Perspective; International Youth Alliance for Family Planning Canada (IYAFP Canada): Ottawa, ON, Canada, 2021; pp. 1–19. Available online: https://www.ohchr.org/Documents/Issues/Health/sexual-reproductive-health-covid/CSOs/ngo.iyapfpdf.pdf (accessed on 20 April 2023).
  4. Hussein, J. COVID-19: What implications for sexual and reproductive health and rights globally? Sex. Reprod. Health Matters 2020, 28, 1746065. [Google Scholar] [CrossRef] [PubMed]
  5. Lindberg, L.; Bell, D.; Kantor, L. The sexual and reproductive health of adolescents and young adults during the COVID-19 pandemic. Perspect. Sex. Reprod. Health 2020, 52, 75–79. [Google Scholar] [CrossRef] [PubMed]
  6. Tang, K.; Gaoshan, J.; Ahonsi, B.; Ali, M.; Bonet, M.; Broutet, N.; Kara, E.; Kim, C.; Thorson, A.; Thwin, S.S. Sexual and reproductive health (SRH): A key issue in the emergency response to the coronavirus disease (COVID-19) outbreak. Reprod. Health 2020, 17, 59. [Google Scholar] [CrossRef] [PubMed]
  7. Church, K.; Gassner, J.; Elliott, M. Reproductive health under COVID-19—Challenges of responding in a global crisis. Sex. Reprod. Health Matters 2020, 28, 1773163. [Google Scholar] [CrossRef]
  8. Wood, J.; Quinn-Nilas, C.; McKay, A.; Wentland, J. Perceived impact of COVID-19 on sexual health and access to sexual health services among university students in Canada. Can. J. Hum. Sex. 2022, 31, 79–90. [Google Scholar] [CrossRef]
  9. VandeVusse, A.; Castillo, P.W.; Kirstein, M.; Mueller, J.; Kavanaugh, M. Disruptions and opportunities in sexual and reproductive health care: How COVID-19 impacted service provision in three US states. Perspect. Sex. Reprod. Health 2022, 54, 188–197. [Google Scholar] [CrossRef]
  10. Morton, S.; Pencheon, D.; Squires, N. Sustainable Development Goals (SDGs), and their implementation: A national global framework for health, development and equity needs a systems approach at every level. Br. Med. Bull. 2017, 124, 81–90. [Google Scholar] [CrossRef]
  11. Urick, B.Y.; Meggs, E.V. Towards a greater professional standing: Evolution of pharmacy practice and education, 1920–2020. Pharmacy 2019, 7, 98. [Google Scholar] [CrossRef]
  12. Carmichael, J.M.; Hall, D.L. Evolution of ambulatory care pharmacy practice in the past 50 years. Am. J. Health Syst. Pharm. 2015, 72, 2087–2091. [Google Scholar] [CrossRef]
  13. Clark, J.S.; Knoer, S.J.; Waier, K.A.; Montgomery, D.R.; Cesarz, J.; Chapman, N.R.M.; Kotis, D. Maximizing pharmacists’ scope of practice. Am. J. Health Syst. Pharm. 2022, 79, 1397–1401. [Google Scholar] [CrossRef]
  14. Weir, N.M.; Newham, R.; Dunlop, E.; Bennie, M. Factors influencing national implementation of innovations within community pharmacy: A systematic review applying the Consolidated Framework for Implementation Research. Implement. Sci. 2019, 14, 21. [Google Scholar] [CrossRef] [PubMed]
  15. Gauly, J.; Ross, J.; Hall, I.; Soda, I.; Atherton, H. Pharmacy-based sexual health services: A systematic review of experiences and attitudes of pharmacy users and pharmacy staff. Sex. Transm. Infect. 2019, 95, 488–495. [Google Scholar] [CrossRef] [PubMed]
  16. Navarrete, J.; Yuksel, N.; Schindel, T.J.; Hughes, C.A. Sexual and reproductive health services provided by community pharmacists: A scoping review. BMJ Open 2021, 11, e047034. [Google Scholar] [CrossRef]
  17. International Pharmaceutical Federation. FIP Report on Engagement with Our Membership 2021—Capturing the Voice of FIP Members Globally, to Advance Pharmacy Worldwide; International Pharmaceutical Federation: The Hague, The Netherlands, 2022; Available online: https://www.fip.org/file/5157 (accessed on 4 April 2023).
  18. Raza, M.A.; Aziz, S.; Noree, M.; Anjum, I.; Raza, S.M. A Portrait of the Pharmacy Profession Globally: Pharmacist Universal Professional Identity and Establishment of Global Pharmacy Council. Innov. Pharm. 2022, 13, 4. [Google Scholar] [CrossRef]
  19. Bates, I.; Meilianti, S.; Bader, L.; Gandhi, R.; Leng, R.; Galbraith, K. Strengthening Primary Healthcare through accelerated advancement of the global pharmacy workforce: A cross-sectional survey of 88 countries. BMJ Open 2022, 12, e061860. [Google Scholar] [CrossRef] [PubMed]
  20. International Pharmaceutical Federation (FIP). Call to Action to Support Pharmacists and Pharmacy Workers on the Coronavirus COVID-19 Frontline; International Pharmaceutical Federation: The Hague, The Netherlands, 2020; Available online: https://www.fip.org/files/content/publications/2020/FIP-call-to-action-to-support-pharmacists-and-pharmacy-workers-on-the-coronavirus-COVID-19-frontline.pdf (accessed on 30 March 2023).
  21. Gilbert, M.; Chang, H.J.; Ablona, A.; Salway, T.; Ogilvie, G.S.; Wong, J.; Haag, D.; Pedersen, H.N.; Bannar-Martin, S.; Campeau, L.; et al. Accessing needed sexual health services during the COVID-19 pandemic in British Columbia, Canada: A survey of sexual health service clients. Sex. Transm. Infect. 2021, 98, 360–365. [Google Scholar] [CrossRef]
  22. Kelly, D.V.; Kielly, J.; Hughes, C.; Gahagan, J.; Asghari, S.; Hancock, S.; Burt, K.; Smyczek, P.; Charlton, C.; Nguyen, H. Expanding access to HIV testing through Canadian community pharmacies: Findings from the APPROACH study. BMC Public Health 2020, 20, 639. [Google Scholar] [CrossRef]
  23. Soon, J.A.; Whelan, A.M.; Yuksel, N.; Rafie, S. Enhancing access to contraception through pharmacist prescribing across Canada. Can. Pharm. J. 2021, 154, 356–362. [Google Scholar] [CrossRef]
  24. Wong, K.R.; Hum, S.; McCarthy, L.; Dunn, S. Beyond Plan B: A qualitative study of Canadian pharmacists’ emergency contraception counselling practices. JOGC 2017, 39, 1021–1027. [Google Scholar] [CrossRef]
  25. Chanakit, T.; Low, B.Y.; Wongpoowarak, P.; Moolasarn, S.; Anderson, C. A survey of pharmacy education in Thailand. Am. J. Pharm. Educ. 2014, 78, 161. [Google Scholar] [CrossRef]
  26. Supapaan, T.; Low, B.Y.; Wongpoowarak, P.; Moolasarn, S.; Anderson, C. A transition from the BPharm to the PharmD degree in five selected countries. Pharm. Pract. 2019, 17, 1611. [Google Scholar] [CrossRef] [PubMed]
  27. Schindel, T.J.; Yuksel, N.; Hughes, C.A. Prescribing by Pharmacists. In Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy; University of Bath: Bath, UK, 2022; pp. 1–22. [Google Scholar]
  28. Schindel, T.J.; Yuksel, N.; Breault, R.; Daniels, J.; Varnhagen, S.; Hughes, C.A. Pharmacists’ learning needs in the era of expanding scopes of practice: Evolving practices and changing needs. Res. Social. Adm. Pharm. 2019, 15, 448–458. [Google Scholar] [CrossRef] [PubMed]
  29. Nakagawa, S.; Kume, N. Pharmacy practice in Japan. Can. J. Hosp. Pharm. 2017, 70, 232–242. [Google Scholar] [CrossRef] [PubMed]
  30. Kamijo, K.; Kataoka, Y.; Shigemi, D. Challenges of accessing emergency contraceptive pills in Japan. BMJ Sex. Reprod. Health 2021, 47, 232–233. [Google Scholar] [CrossRef] [PubMed]
  31. Taniguchi, H.; Hisasue, S.I.; Sato, Y. Challenges in the practice of sexual medicine in the time of COVID-19 in Japan. J. Sex. Med. 2020, 17, 1237–1238. [Google Scholar] [CrossRef]
  32. Nawanopparatsakul, S.; Keokitichai, S.; Wiyakarn, S.; Chantaraskul, C. Challenges of pharmacy education in Thailand. Silpakorn Univ. Int. J. 2010, 9–10, 19–39. [Google Scholar]
  33. Jaisue, S. Pharmacy practice in Thailand. J. Pharm. Pract. Res. 2015, 45, 390–391. [Google Scholar] [CrossRef]
  34. Regional Office for the Western Pacific. The Kingdom of Thailand Health System Review; WHO Regional Office for the Western Pacific: Manila, Philippines, 2015; p. 265. Available online: https://apps.who.int/iris/handle/10665/208216 (accessed on 25 March 2023).
  35. Suwannaprom, P.; Suttajit, S.; Eakanunkul, S.; Supapaan, T.; Kessomboon, N.; Udomaksorn, K.; Sakulbumrungsil, R. Development of pharmacy competency framework for the changing demands of Thailand’s pharmaceutical and health services. Pharm. Pract. 2020, 18, 2141. [Google Scholar] [CrossRef]
  36. Panichkriangkrai, W.; Topothai, C.; Saengruang, N.; Thammatach-Aree, J.; Tangcharoensathien, V. Universal access to sexual and reproductive health services in Thailand: Achievements and challenges. Sex. Reprod. Health Matters 2020, 28, 1805842. [Google Scholar] [CrossRef]
  37. Andajani, S.; Chanthasukh, S.; Fairbairn-Dunlop, P.; Smith, J.F. Community pharmacists’ roles in providing contraceptive services: Views and experiences of adolescents in urban Khon Kaen, Northeast Thailand. Int. J. Pharm. Pract. 2023, 31, 276–281. [Google Scholar] [CrossRef]
  38. Iguchi, K.; Ueyama, M.; Nishio, H.; Tamaki, H.; Osanai, A.; Ino, Y.; Nonomura, K.; Horibe, M.; Matsunaga, T.; Nakamura, M. Impact of the increase in the number of community pharmacists on their geographical distribution in Japan: A retrospective survey. J. Pharm. Policy Pract. 2022, 15, 96. [Google Scholar] [CrossRef] [PubMed]
  39. National Association of Pharmacy Regulatory Authorities. National Statistics. Available online: https://www.napra.ca/resources/national-statistics/ (accessed on 30 March 2023).
  40. The Pharmacy Council of Thailand. Number of Licensed Pharmacists to Practice Pharmacy Each Year. Available online: https://www.pharmacycouncil.org/index.php?option=content&menuid=33 (accessed on 30 March 2023).
  41. Statista. Health. Pharma & Medtech. Available online: https://www.statista.com/markets/412/health-pharma-medtech/ (accessed on 30 March 2023).
  42. Canadian Institute for Health Information. Pharmacists in Canada, 2021—Data Tables; CIHI: Ottawa, ON, Canada, 2022; Available online: https://www.cihi.ca/en/pharmacists (accessed on 30 March 2023).
  43. Canadian Pharmacists Association. CPhA Position Statement—Doctor of Pharmacy Degree as an Entry-Level to Practice; Canadian Pharmacists Association: Toronto, ON, Canada, 2011; Available online: https://www.pharmacists.ca/cpha-ca/assets/File/cpha-on-the-issues/PharmD%20Entry%20Level.pdf (accessed on 20 April 2023).
  44. Suttajit, S.; Suwannaprom, P.; Supapaan, T.; Eakanunkul, S.; Tangkiatkumjai, M.; Kongkaew, C.; Anderson, C.; Wongpoowarak, P. Are we on the right track? Answers from a national survey of Thai graduates’ perceptions during the transition to the 6-year PharmD program. Adv. Med. Educ. Pract. 2018, 9, 713–722. [Google Scholar] [CrossRef] [PubMed]
  45. Hasumoto, K.Y.; Thomas, R.K.; Yokoi, M.; Arai, K. Comparison of community pharmacy practice in Japan and US state of Illinois. J. Pharm. Pract. 2020, 33, 48–54. [Google Scholar] [CrossRef]
  46. Chaiyakunapruk, N.; Jones, S.M.; Dhippayom, T.; Sumpradit, N. Pharmacy practice in Thailand. In Pharmacy Practice in Developing Countries; Elsevier: Amsterdam, The Netherlands, 2016; pp. 3–22. [Google Scholar]
  47. Leelavanich, D.; Adjimatera, N.; Broese Van Groenou, L.; Anantachoti, P. Prescription and non-prescription drug classification systems across countries: Lessons learned for Thailand. Risk Manag. Healthc. Policy 2020, 13, 2753–2768. [Google Scholar] [CrossRef] [PubMed]
  48. Utsumi, M.; Hirano, S.; Fujii, Y.; Yamamoto, H. Evaluation of the pharmacy practice program in the 6-year pharmaceutical education curriculum in Japan: Community pharmacy practice program. J. Pharm. Health Care Sci. 2015, 1, 27. [Google Scholar] [CrossRef] [PubMed]
  49. Von Elm, E.; Altman, D.G.; Egger, M.; Pocock, S.J.; Gotzsche, P.C.; Vandenbroucke, J.P.; Initiative, S. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. J. Clin. Epidemiol. 2008, 61, 344–349. [Google Scholar] [CrossRef] [PubMed]
  50. Harris, P.A.; Taylor, R.; Thielke, R.; Payne, J.; Gonzalez, N.; Conde, J.G. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 2009, 42, 377–381. [Google Scholar] [CrossRef]
  51. Harris, P.A.; Taylor, R.; Minor, B.L.; Elliott, V.; Fernandez, M.; O’Neal, L.; McLeod, L.; Delacqua, G.; Delacqua, F.; Kirby, J.; et al. The REDCap consortium: Building an international community of software platform partners. J. Biomed. Inform. 2019, 95, 103208. [Google Scholar] [CrossRef]
  52. Yamamura, S.; Terajima, T.; Navarrete, J.; Hughes, C.A.; Yuksel, N.; Schindel, T.J.; Sriboonruang, T.; Anantachoti, P.; Patikorn, C. Reproductive health services: Attitudes and practice of Japanese community pharmacists. Healthcare 2021, 9, 1336. [Google Scholar] [CrossRef]
  53. Navarrete, J.; Hughes, C.A.; Yuksel, N.; Schindel, T.J.; Makowsky, M.J.; Yamamura, S. Community pharmacists’ provision of sexual and reproductive health services: A cross-sectional study in Alberta, Canada. J. Am. Pharm. Assoc. 2022, 62, 1214–1223. [Google Scholar] [CrossRef]
  54. Saleh, A.; Bista, K. Examining factors impacting online survey response rates in educational research: Perceptions of graduate students. J. Multidiscip. Eval. 2017, 13, 63–74. [Google Scholar] [CrossRef]
  55. Blumenberg, C.; Menezes, A.M.B.; Gonçalves, H.; Assunção, M.C.F.; Wehrmeister, F.C.; Barros, F.C.; Barros, A.J.D. The role of questionnaire length and reminders frequency on response rates to a web-based epidemiologic study: A randomised trial. Int. J. Soc. Res. Methodol. 2019, 22, 625–635. [Google Scholar] [CrossRef]
  56. Archer, T. Characteristics associated with increasing the response rates of web-based surveys. Pract. Assess. Res. Eval. 2007, 12, 12. [Google Scholar] [CrossRef]
  57. Canadian Pharmacists Association. Pharmacists’ Expanded Scope of Practice in Canada. Available online: https://www.pharmacists.ca/pharmacy-in-canada/scope-of-practice-canada/ (accessed on 2 April 2023).
  58. Kodama, T.; Nakase, K.; Tsuda, T.; Yorifuji, T.; Doi, H. Factors affecting appropriate management of patients with sexually transmitted infections in Japan. Acta Med. Okayama 2010, 64, 171–179. [Google Scholar] [PubMed]
  59. Ngatu, N.R.; Hirota, R.; Eitoku, M.; Muzembo, B.A.; Nishimori, M.; Kuramochi, M.; Shintani, S.; Inoue, S.; Takiuchi, R.; Maegawa, M.; et al. Perception of the risk of sexual transmission of HIV among Congolese and Japanese university students. Environ. Health Prev. Med. 2012, 17, 139–146. [Google Scholar] [CrossRef] [PubMed]
  60. Ono-Kihara, M.; Kihara, M.; Yamazaki, H. Sexual practices and the risk for HIV/STDs infection of youth in Japan. JMAJ 2002, 45, 520–525. [Google Scholar]
  61. Cappiello, J.; Levi, A.; Nothnagle, M. Core competencies in sexual and reproductive health for the interprofessional primary care team. Contraception 2016, 93, 438–445. [Google Scholar] [CrossRef]
  62. Nordin, N.; Ahmad Hassali, M.A.; Sarriff, A. A global picture of extended pharmacy services, perceptions, and barriers toward its performance: A systematic review. Asian J. Pharm. Clin. Res. 2017, 10, 417–427. [Google Scholar] [CrossRef]
  63. Alberta Health Services. Syphilis Outbreak, Information for Albertans. Available online: https://www.albertahealthservices.ca/info/Page17087.aspx (accessed on 15 March 2023).
  64. Alberta Health Services. Alberta Sexually Transmitted Infections and HIV. 2020. Available online: https://open.alberta.ca/dataset/c6850032-20d3-4845-a465-568ed7e61b7c/resource/a50e1cd7-a968-480a-a4a4-332ddbf13597/download/health-alberta-sexually-transmitted-infections-and-hiv-2020.pdf (accessed on 20 April 2023).
  65. Public Health Agency of Canada. Report on Sexually Transmitted Infections in Canada, 2018; Ministry of Health: Ottawa, ON, Canada, 2021. Available online: https://www.canada.ca/content/dam/hc-sc/documents/services/publications/diseases-conditions/report-sexually-transmitted-infections-canada/report-sexually-transmitted-infections-canada-2018.pdf (accessed on 30 March 2023).
  66. Kongkanand, A.; Permpongkosol, S.; Tantiwongse, K. Thai men’s health and sexual attitude. Asian J. Androl. 2011, 13, 534–536. [Google Scholar] [CrossRef]
  67. Srithanaphakarangkul, K. Prevalence of sexual dysfunction and sexual attitudes among postmenopausal female patients in Phramongkutklao hospital. J. Southeast Asian Med. Res. 2019, 3, 82–87. [Google Scholar] [CrossRef]
  68. Sansone, A.; Cuzin, B.; Jannini, E.A. Facing counterfeit medications in sexual medicine: A systematic scoping review on social strategies and technological solutions. Sex. Med. 2021, 9, 100437. [Google Scholar] [CrossRef] [PubMed]
Healthcare 11 01530 g001 550
Figure 1. Comparison of attitudes towards the provision of sexual and reproductive health professional pharmacy services. (SRHS = Sexual and reproductive health services).
Figure 1. Comparison of attitudes towards the provision of sexual and reproductive health professional pharmacy services. (SRHS = Sexual and reproductive health services).
Healthcare 11 01530 g001
Healthcare 11 01530 g002 550
Figure 2. Comparison of perceived factors influencing the provision of sexual and reproductive health professional pharmacy services.
Figure 2. Comparison of perceived factors influencing the provision of sexual and reproductive health professional pharmacy services.
Healthcare 11 01530 g002
Healthcare 11 01530 g003 550
Figure 3. Comparison of preferences for additional training on sexual and reproductive health topics.
Figure 3. Comparison of preferences for additional training on sexual and reproductive health topics.
Healthcare 11 01530 g003
Healthcare 11 01530 g004 550
Figure 4. Comparison of training interests in sexual and reproductive health competencies.
Figure 4. Comparison of training interests in sexual and reproductive health competencies.
Healthcare 11 01530 g004
Table
Table 2. Procedures for data collection.
Table 2. Procedures for data collection.
JapanThailandCanada
Recruitment strategyEmails were sent to contact lists from pharmacy professional organizations, pharmacy and drugstore chains, and community pharmacist groups. Attendees of continuing education conferences. Facebook and Twitter promotion [52].Emails sent to contact list from regional professional pharmacy associations Emails sent to contact list from the regional professional regulatory body (Alberta)
DistributionEmailEmailEmail
Total number of pharmacists contactedN/A760 *5349 *
Responses53485303
Estimated
response rate		N/AN/A8% [53]
RemindersNone33
Dates of data collectionNovember 2020–
April 2021		December 2020–
June 2021		June 2020–
July 2020
Duration of open survey6 months6 months2 months
IncentiveNoneNone$100 gift card draw (odds of winning 1 in 10)
* Total number of people contacted. This number includes pharmacists working in different settings, not only community pharmacy. N/A, not available.
Table
Table 3. Participants characteristics.
Table 3. Participants characteristics.
CharacteristicsJapan
(N = 534)
n (%)		Thailand
(N = 85)
n (%)		Canada
(N = 303)
n (%)
Gender
  Female295 (55)54 (64)199 (66)
Age range
  20–30 years208 (39)17 (20)71 (24)
  31–40 years116 (22)40 (47)120 (40)
  41–50 years97 (18)11 (13)60 (20)
  51–60 years81 (15)8 (9)41 (14)
  61–70 years29 (5)7 (8)9 (3)
  71+ years3 (1)2 (2)0 (0)
Professional Education
  Bachelor of Pharmacy (4 years)245 (46)47 (55)239 (79)
  Bachelor of Pharmacy (6 years)257 (48)--
  Doctor of Pharmacy (PharmD)-21 (25)32 (11)
  Residency--3 (1)
  Post-professional or post-baccalaureate PharmD --3 (1)
  Master (M.Sc. or M.Pharm.)23 (4)12 (14)20 (7)
  Doctor of Philosophy (Ph.D.)6 (1)2 (2)4 (1)
Years of registration as a pharmacist
  <1 year9 (2)2 (2)16 (5)
  1–5 years214 (40)16 (19)92 (30)
  6–10 years50 (9)21 (25)63 (21)
  11–20 years91 (17)23 (27)68 (22)
  21–30 years95 (18)8 (9)38 (13)
  >31 years74 (14)15 (18)25 (8)
Type of pharmacy
  Independent68 (13)67 (79)83 (27)
  Corporate/chain322 (61)12 (14)172 (57)
  Banner/franchise1 (0)6 (7)44 (15)
  Drugstore chain135 (26)--
  Other4 (1)0 (0)3 (1)
Table
Table 4. Sexual and reproductive health services provided by community pharmacists.
Table 4. Sexual and reproductive health services provided by community pharmacists.
ServiceCountry
Japan
(N = 534)
n (%)		Thailand
(N = 85)
n (%)		Canada
(N = 303)
n (%)
  • Pregnancy Tests
Patient education on pregnancy tests 192 (36)83 (98)211 (70)
2.
Ovulation Tests
Patient education on ovulation tests 222 (42)70 (83)152 (50)
3.
Contraception
Provide
  Combined hormonal contraceptives 250 (47)84 (99)298 (98)
Patient education on
  Combined hormonal contraceptives 207 (39)84 (99)295 (97)
  Barrier contraception for men 299 (56)67 (79)210 (69)
4.
Emergency contraception
Provision of EC pills (Levonorgestrel only pills, e.g., Plan B®) 37 (7)82 (98)294 (97)
Patient education on EC (Levonorgestrel only pills, e.g., Plan B®) 81 (15)84 (99)296 (98)
5.
STBBI (chlamydia, gonorrhea, hepatitis B and C, genital herpes, syphilis, trichomoniasis, HIV, HPV)
Patient education on STBBI treatment 96 (18)82 (97)247 (82)
Patient education on STBBI prevention68 (13)80 (94)216 (71)
6.
Maternal and perinatal health
Patient education on nutrition and vitamin supplementation for prenatal and pregnancy care 253 (48)79 (93)278 (92)
Provision of information on safety of medications in pregnancy395 (74)85 (100)297 (98)
Provision of information of recommended vaccines prior to and during pregnancy 139 (26)39 (46)259 (86)
Provision of information on safety of medications in breastfeeding 408 (76)85 (100)298 (98)
7.
General Sexual Health
Patient education on sexual dysfunction related to medications 159 (30)51 (61)255 (84)
Assist female patients identify/select options for sexual dysfunction 61 (11)33 (39)102 (34)
Assist male patients identify/select options for sexual dysfunction67 (13)53 (63)207 (68)
Address sexual health concerns/needs of LGBTQ+ patients 95 (18)40 (48)132 (44)
EC, emergency contraception; STBBI, sexually transmitted and blood-borne infection; HIV, human immunodeficiency virus; HPV, human papillomavirus; LGBTQ+, lesbian, gay, bisexual, transgender, and queer (or questioning) and others.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Navarrete, J.; Hughes, C.A.; Yuksel, N.; Schindel, T.J.; Yamamura, S.; Terajima, T.; Sriboonruang, T.; Patikorn, C.; Anantachoti, P. Community Pharmacists’ Experiences and Attitudes towards the Provision of Sexual and Reproductive Health Services: An International Survey. Healthcare 2023, 11, 1530. https://doi.org/10.3390/healthcare11111530

AMA Style

Navarrete J, Hughes CA, Yuksel N, Schindel TJ, Yamamura S, Terajima T, Sriboonruang T, Patikorn C, Anantachoti P. Community Pharmacists’ Experiences and Attitudes towards the Provision of Sexual and Reproductive Health Services: An International Survey. Healthcare. 2023; 11(11):1530. https://doi.org/10.3390/healthcare11111530

Chicago/Turabian Style

Navarrete, Javiera, Christine A. Hughes, Nese Yuksel, Theresa J. Schindel, Shigeo Yamamura, Tomoko Terajima, Tatta Sriboonruang, Chanthawat Patikorn, and Puree Anantachoti. 2023. "Community Pharmacists’ Experiences and Attitudes towards the Provision of Sexual and Reproductive Health Services: An International Survey" Healthcare 11, no. 11: 1530. https://doi.org/10.3390/healthcare11111530

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop